Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry.
Fox KAA, Aboyans V, Debus ES, Zeymer U, Cowie MR, Patel M, Welsh RC, Bosch J, Gay A, Vogtländer K, Anand SS. Fox KAA, et al. Among authors: zeymer u. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):825-836. doi: 10.1093/ehjcvp/pvac028. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35594542 Clinical Trial.
Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both.
Fox KAA, Anand SS, Aboyans V, Cowie MR, Debus ES, Zeymer U, Monje D, Vogtländer K, Lawatscheck R, Gay A. Fox KAA, et al. Among authors: zeymer u. Am Heart J. 2020 Apr;222:166-173. doi: 10.1016/j.ahj.2020.01.015. Epub 2020 Jan 28. Am Heart J. 2020. PMID: 32092505 Clinical Trial.
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trial.
Heer T, von Scheidt M, Boening A, Heyken C, Gusmini F, de Waha A, Kuna C, Fach A, Grothusen C, Oberhoffer M, Knosalla C, Walther T, Danner BC, Misfeld M, Wimmer-Greinecker G, Siepe M, Grubitzsch H, Joost A, Schaefer A, Conradi L, Cremer J, Hamm C, Lange R, Radke PW, Schulz R, Laufer G, Grieshaber P, Attmann T, Schmoeckel M, Meyer A, Ziegelhöffer T, Hambrecht R, Sandner SE, Kastrati A, Schunkert H, Zeymer U. Heer T, et al. Among authors: zeymer u. Eur J Cardiothorac Surg. 2022 Aug 3;62(3):ezac048. doi: 10.1093/ejcts/ezac048. Eur J Cardiothorac Surg. 2022. PMID: 35138350 Clinical Trial.
618 results